ImpediMed Limited (IPD.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 10.31 Million AUD | -9.04% |
| 2023 | 11.34 Million AUD | 7.36% |
| 2022 | 10.56 Million AUD | 25.65% |
| 2021 | 8.4 Million AUD | 46.47% |
| 2020 | 5.74 Million AUD | 38.14% |
| 2019 | 4.15 Million AUD | 25.26% |
| 2018 | 3.31 Million AUD | -42.46% |
| 2017 | 5.76 Million AUD | -0.43% |
| 2016 | 5.79 Million AUD | 19.55% |
| 2015 | 4.84 Million AUD | 37.57% |
| 2014 | 3.52 Million AUD | 28.83% |
| 2013 | 2.73 Million AUD | -7.2% |
| 2012 | 2.94 Million AUD | -24.23% |
| 2011 | 3.88 Million AUD | 6.82% |
| 2010 | 3.63 Million AUD | 21.63% |
| 2009 | 2.99 Million AUD | 29.44% |
| 2008 | 2.31 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.78 Million AUD | 0.0% |
| 2024 FY | 10.31 Million AUD | -9.04% |
| 2024 Q4 | 5.53 Million AUD | 0.0% |
| 2023 Q2 | 5.65 Million AUD | 0.0% |
| 2023 FY | 11.34 Million AUD | 7.36% |
| 2023 Q4 | 5.68 Million AUD | 0.0% |
| 2022 Q4 | 5.37 Million AUD | 0.0% |
| 2022 FY | 10.56 Million AUD | 25.65% |
| 2022 Q2 | 5.19 Million AUD | 0.0% |
| 2021 Q4 | 4.83 Million AUD | 0.0% |
| 2021 Q2 | 3.57 Million AUD | 0.0% |
| 2021 FY | 8.4 Million AUD | 46.47% |
| 2020 Q2 | 2.83 Million AUD | 0.0% |
| 2020 Q4 | 2.9 Million AUD | 0.0% |
| 2020 FY | 5.74 Million AUD | 38.14% |
| 2019 Q4 | 2.32 Million AUD | 0.0% |
| 2019 Q2 | 1.8 Million AUD | 0.0% |
| 2019 FY | 4.15 Million AUD | 25.26% |
| 2018 Q2 | 1.51 Million AUD | 0.0% |
| 2018 FY | 3.31 Million AUD | -42.46% |
| 2018 Q4 | 1.8 Million AUD | 0.0% |
| 2017 FY | 5.76 Million AUD | -0.43% |
| 2017 Q2 | 2.87 Million AUD | 0.0% |
| 2017 Q4 | 2.89 Million AUD | 0.0% |
| 2016 Q4 | 3.08 Million AUD | 0.0% |
| 2016 FY | 5.79 Million AUD | 19.55% |
| 2016 Q2 | 2.71 Million AUD | 0.0% |
| 2015 FY | 4.84 Million AUD | 37.57% |
| 2015 Q2 | 2.08 Million AUD | 0.0% |
| 2015 Q4 | 2.76 Million AUD | 0.0% |
| 2014 Q4 | 1.91 Million AUD | 0.0% |
| 2014 FY | 3.52 Million AUD | 28.83% |
| 2014 Q2 | 1.61 Million AUD | 0.0% |
| 2013 Q2 | 1.26 Million AUD | 0.0% |
| 2013 Q4 | 1.47 Million AUD | 0.0% |
| 2013 FY | 2.73 Million AUD | -7.2% |
| 2012 Q3 | 736.25 Thousand AUD | 0.0% |
| 2012 FY | 2.94 Million AUD | -24.23% |
| 2012 Q2 | 736.25 Thousand AUD | -24.23% |
| 2012 Q1 | 971.75 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | -100.0% |
| 2011 Q1 | 909.75 Thousand AUD | 0.0% |
| 2011 Q2 | 971.75 Thousand AUD | 6.82% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | 3.88 Million AUD | 6.82% |
| 2011 Q3 | 971.75 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 909.75 Thousand AUD | 0.0% |
| 2010 FY | 3.63 Million AUD | 21.63% |
| 2010 Q2 | 909.75 Thousand AUD | 21.63% |
| 2010 Q1 | 747.98 Thousand AUD | 0.0% |
| 2009 Q3 | 747.98 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2009 Q2 | 747.98 Thousand AUD | 27.78% |
| 2009 Q1 | 585.37 Thousand AUD | 0.0% |
| 2009 FY | 2.99 Million AUD | 29.44% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q2 | 585.37 Thousand AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2008 FY | 2.31 Million AUD | 0.0% |
| 2008 Q3 | 585.37 Thousand AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -174.861% |
| Adherium Limited | 840.98 Thousand AUD | -1127.018% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 83.713% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -152.512% |
| Anteris Technologies Ltd | 4.11 Million AUD | -151.005% |
| Control Bionics Limited | 5.12 Million AUD | -101.272% |
| CardieX Limited | 10.9 Million AUD | 5.379% |
| Compumedics Limited | 49.71 Million AUD | 79.245% |
| Cochlear Limited | 2.25 Billion AUD | 99.543% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 34.365% |
| Cyclopharm Limited | 27.13 Million AUD | 61.978% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 8.024% |
| Nova Eye Medical Limited | 23.32 Million AUD | 55.76% |
| HeraMED Limited | 402.89 Thousand AUD | -2461.201% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -1576.338% |
| InhaleRx Limited | 1.2 Million AUD | -757.027% |
| LBT Innovations Limited | 1.25 Million AUD | -721.576% |
| Micro-X Limited | 15.22 Million AUD | 32.21% |
| Neurotech International Limited | 1963.00 AUD | -525574.987% |
| OncoSil Medical Limited | 1.56 Million AUD | -559.2% |
| PolyNovo Limited | 103.19 Million AUD | 90.0% |
| Respiri Limited | 456.91 Thousand AUD | -2158.412% |
| SomnoMed Limited | 91.65 Million AUD | 88.741% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -55.574% |
| Uscom Limited | 3.72 Million AUD | -176.883% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -19.02% |